HUP0302522A3 - Thermoformable solid pharmaceutical composition for controlled release of ivabradine - Google Patents

Thermoformable solid pharmaceutical composition for controlled release of ivabradine

Info

Publication number
HUP0302522A3
HUP0302522A3 HU0302522A HUP0302522A HUP0302522A3 HU P0302522 A3 HUP0302522 A3 HU P0302522A3 HU 0302522 A HU0302522 A HU 0302522A HU P0302522 A HUP0302522 A HU P0302522A HU P0302522 A3 HUP0302522 A3 HU P0302522A3
Authority
HU
Hungary
Prior art keywords
ivabradine
pharmaceutical composition
controlled release
solid pharmaceutical
thermoformable
Prior art date
Application number
HU0302522A
Other languages
English (en)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HUP0302522A2 publication Critical patent/HUP0302522A2/hu
Publication of HUP0302522A3 publication Critical patent/HUP0302522A3/hu
Publication of HU229410B1 publication Critical patent/HU229410B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0302522A 2000-12-26 2001-12-21 Ivabradine containing solid thermoformed pharmaceutical composition for controlled release HU229410B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017015A FR2818552B1 (fr) 2000-12-26 2000-12-26 Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
PCT/FR2001/004134 WO2002051387A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Publications (3)

Publication Number Publication Date
HUP0302522A2 HUP0302522A2 (hu) 2003-12-29
HUP0302522A3 true HUP0302522A3 (en) 2007-09-28
HU229410B1 HU229410B1 (en) 2013-12-30

Family

ID=8858190

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302522A HU229410B1 (en) 2000-12-26 2001-12-21 Ivabradine containing solid thermoformed pharmaceutical composition for controlled release

Country Status (27)

Country Link
US (1) US20040028743A1 (hu)
EP (1) EP1345594B1 (hu)
JP (2) JP2004518665A (hu)
KR (1) KR100542472B1 (hu)
CN (1) CN1203844C (hu)
AT (1) ATE352290T1 (hu)
AU (1) AU2002228119B2 (hu)
BR (1) BR0116548A (hu)
CA (1) CA2432645A1 (hu)
CY (1) CY1106390T1 (hu)
CZ (1) CZ304587B6 (hu)
DE (1) DE60126332T2 (hu)
DK (1) DK1345594T3 (hu)
EA (1) EA005814B1 (hu)
ES (1) ES2280420T3 (hu)
FR (1) FR2818552B1 (hu)
HK (1) HK1060514A1 (hu)
HU (1) HU229410B1 (hu)
MX (1) MXPA03005840A (hu)
NO (1) NO333776B1 (hu)
NZ (1) NZ526406A (hu)
PL (1) PL203835B1 (hu)
PT (1) PT1345594E (hu)
SI (1) SI1345594T1 (hu)
SK (1) SK286413B6 (hu)
WO (1) WO2002051387A1 (hu)
ZA (1) ZA200304441B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
FR2882556B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2010128525A2 (en) * 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
CA2800444C (en) 2010-06-14 2018-03-20 Ratiopharm Gmbh Ivabradine-containing pharmaceutical composition
CN101897682B (zh) * 2010-07-13 2012-02-15 石药集团欧意药业有限公司 一种伊伐布雷定或其可药用盐固体制剂及其制备方法
CN102908327B (zh) * 2011-08-05 2015-03-11 江苏恒瑞医药股份有限公司 伊伐布雷定或其可药用盐的缓释制剂
EP3082772A1 (en) * 2013-12-20 2016-10-26 Synhton B.V. Pharmaceutical composition comprising amorphous ivabradine
EP3025705B8 (en) 2014-11-25 2018-11-28 Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi Stable ivabradine formulations
CN104398486B (zh) * 2014-12-08 2018-01-12 武汉武药科技有限公司 一种盐酸伊伐布雷定渗透泵控释片及其制备方法
EP3366282A1 (en) 2017-02-28 2018-08-29 Sanovel Ilac Sanayi ve Ticaret A.S. Solid oral pharmaceutical compositions of ivabradine
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997008950A1 (en) * 1995-09-07 1997-03-13 Fuisz Technologies, Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
DK0998272T3 (da) * 1997-08-26 2003-08-25 Aventis Pharma Inc Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
DE19901040A1 (de) * 1999-01-14 2000-07-20 Knoll Ag Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine

Also Published As

Publication number Publication date
HU229410B1 (en) 2013-12-30
AU2002228119B2 (en) 2006-04-27
CZ304587B6 (cs) 2014-07-23
CY1106390T1 (el) 2011-10-12
EA005814B1 (ru) 2005-06-30
SI1345594T1 (sl) 2007-04-30
KR100542472B1 (ko) 2006-01-11
EA200300667A1 (ru) 2003-12-25
PL203835B1 (pl) 2009-11-30
HUP0302522A2 (hu) 2003-12-29
CA2432645A1 (fr) 2002-07-04
ZA200304441B (en) 2004-06-25
FR2818552A1 (fr) 2002-06-28
NO20032737L (no) 2003-06-16
JP2004518665A (ja) 2004-06-24
PT1345594E (pt) 2007-04-30
NZ526406A (en) 2005-08-26
SK286413B6 (sk) 2008-09-05
WO2002051387A8 (fr) 2004-05-13
BR0116548A (pt) 2003-12-23
FR2818552B1 (fr) 2003-02-07
ES2280420T3 (es) 2007-09-16
DE60126332T2 (de) 2007-08-30
PL361662A1 (en) 2004-10-04
CN1482901A (zh) 2004-03-17
WO2002051387A1 (fr) 2002-07-04
SK9422003A3 (en) 2003-12-02
DE60126332D1 (de) 2007-03-15
NO20032737D0 (no) 2003-06-16
KR20030064876A (ko) 2003-08-02
EP1345594A1 (fr) 2003-09-24
DK1345594T3 (da) 2007-05-21
EP1345594B1 (fr) 2007-01-24
CZ20032020A3 (cs) 2003-11-12
US20040028743A1 (en) 2004-02-12
JP2010100641A (ja) 2010-05-06
MXPA03005840A (es) 2003-09-10
NO333776B1 (no) 2013-09-16
HK1060514A1 (en) 2004-08-13
CN1203844C (zh) 2005-06-01
ATE352290T1 (de) 2007-02-15

Similar Documents

Publication Publication Date Title
HUP0002469A3 (en) Solid thermoformable controlled-release pharmaceutical composition
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU9208601A (en) Delayed release pharmaceutical formulations
HUP0300373A3 (en) Sustained release vitamin composition and process for their preparation
HUP0301242A3 (en) Controlled release drug dosage form
EP1383376A4 (en) PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
HUP0300541A3 (en) Pharmaceutical compositions for sustained release, containing fluvastatin
AU2001286677A1 (en) Controlled release of substances
HUP0302522A3 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
HUP0301842A3 (en) Lactam compound, pharmaceutical composition containing it and use of it for producing pharmaceutical composition
AU2003213151A1 (en) Controlled release solid dosage carbamazepine formulations
EP1424994A4 (en) PREPARATION OF A SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
EP1225971A4 (en) CONTROLLED RELEASE OF SUBSTANCES
EG24463A (en) Modified release pharmaceutical composition
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
AU2001232948A1 (en) Controlled release of drugs
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
EP1501352A4 (en) METHOD AND COMPOSITIONS FOR PROTRACTED ACTIVE SUBSTANCE
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
GB2377888B (en) Sustained release pharmaceutical composition containing glipizide and method for producing same
IL152243A0 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
EP1404301A4 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE, STABLE, CONTAINING PRAVASTATIN
HUP0302524A3 (en) Thermoformable solid pharmaceutical composition for controlled release of perindopril

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees